Table 3.
Marker | Class | Function | Abnormality | NMSC | HNSCC | ESCC | NSCLC |
---|---|---|---|---|---|---|---|
TP53 | CCR | Tumor-suppressor gene regulating cell-cycle progression and cell survival | GE, GM | • | • | • | • |
pRB | CCR | Tumor-suppressor gene regulating cell-cycle progression and apoptosis | GE | •[237] | |||
p16 | CCR | Tumor-suppressor gene regulating senescence and cell-cycle progression | GM, M | • | • | ||
PTEN | CCR | Tumor-suppressor gene controlling cell proliferation and apoptosis | GE | •[237] | |||
MKI67 (Ki-67) | CCR | Proto-oncogene regulating cell proliferation, increased from normal to pre-cancer | GE | • | • | • | • |
CCND1 | CCR | Proto-oncogene regulating cell-cycle progression | GE | • | • | • | |
p63 | CCR | A member of the p53 family of transcription factors | GE | • | • | • | • |
p27 | CCR | G1 arrest | GE | •[238] | |||
CD95 | CCR | Death ligands | GE | •[239] | |||
FHIT | CCR | Negative regulation of progression through cell cycle | GE | •[240] | |||
Bcl-x | CCR | regulate programmed cell death | GE | •[235] | |||
Bcl-2 | CCR | regulate programmed cell death | GE | •[103] | |||
Bax | CCR | regulate programmed cell death | GE | •[236] | |||
EGFR | ST | Transmembrane TK acting as a central transducer of multiple signaling pathways | GE, GM | • | • | • | • |
VEGF | ST | Transmembrane TK that promotes the proliferation, migration, and survival of endothelial cells during tumor growth | GE | • | • | ||
HER2 | ST | Cell membrane surface-bound receptor tyrosine kinase leading to cell growth and differentiation | GE | •[241] | •[234] | ||
Annexin I | ST | Cell surface receptor linked signal transduction | GE | •[242] | |||
RRas2 | ST | Small GTPase mediated signal transduction | GE, GM | •[243] | |||
Smad6/7 | ST | TGF beta receptor signaling pathway | GE | •[229] | |||
NKX2-1 (TTF-1) | ST | Regulates gene trancription | GE, GM | • | |||
BRAF | ST | Protein kinase is involved in sending signals in cells and in cell growth | GE, GM | • | |||
c-MET | ST | Membrane receptor that is essential for embryonic development and wound healing | GE, GM | • | |||
PEDF | ST | Serine protease inhibitor | GE | •[244] | |||
PIK3CA | ST | Phosphatidylinositol 3-kinase | GE, GM | • | |||
LKB1 | ST | Protein kinase regulates cell polarity and functions as a tumor suppressor | GE, GM | • | |||
RASSF1A | ST | Encord protein mediated signal transduction | GE, M | • | |||
CD24 | ST | Encord protein mediated signal transduction | GE | •[101] | |||
CD44v6 | CA | Transmembrane glycoproteins that maintain tissue integrity by mediating contact between cells or between cells and the extracellular matrix | GE | •[230] | |||
CDH1 | CA | Ca 2+ -dependent cell-cell adhesion molecule, induce and maintain intercellular connections | GE, M | • | • | ||
Trop2 | CA | Cell adhesion, signal transduction | GE | •[231] | |||
EpCAM | CA | Cell adhesion, signal transduction | GE, GM | •[232] | |||
ALCAM | CA | Cell adhesion, signal transduction | GE | •[245] | |||
MMPs | EMD | A family of zinc-dependent proteolytic enzymes that degrade the basement membrane and other components of the extracellular matrix | GE | • | • | • | |
COX-2 | PM | Prostaglandin metabllism | GE | • | • | • | • |
SOX-2 | TF | Transcription factor | GE | • | • | • | |
AP-1 | TF | Transcript factor | GE | •[246] | |||
PPARb/d | TF | Transcript factor | GE | •[247] | |||
CK-14 | CK | Epidermis development | GE | •[248] | |||
CK-4 | CK | Cytoskeleton organization and biogenesis | GE | •[248] |
CCR = cell-cycle regulation; ST = signal transduction; CA = cell adhesion; EMD = extracellular matrix degradation; PM = protein metabolism; TF = transcript factor; CK = cytokeratin; PK = protein kinase; GE = gene expression; GM = gene mutation; M = methylation